Submitted by Anonymous (not verified) on 5 November 2025 - 14:35
Human medicines European public assessment report (EPAR): Braftovi, encorafenib, Date of authorisation: 19/09/2018, Revision: 17, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Braftovi, encorafenib, Date of authorisation: 19/09/2018, Revision: 17, Status: Authorised